Mizuho Securities Reiterates Buy Rating on CVS Health (CVS) Following 3Q EPS Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St futures rise on tech buying, Middle East peace hopes
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil falls as traders digest escalation in US-Iran strikes
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- SAP stock dips after Oracle's massive AI spending plans
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
- Wall Street indexes fall more than 1%, hit by tech, Iran war worries
- UBS sees generational semiconductor boom, highlights stock winners
CVS Health Reports Third Quarter Results
November 6, 2019 6:30 AM ESTWOONSOCKET, R.I., Nov. 6, 2019 /PRNewswire/ --
Third Quarter Year-over-Year Highlights:
Total revenues increased 36.5% to $64.8 billion GAAP operating income increased 13.8% to $2.9 billion Adjusted operating income (1) increased 48.9% to $3.9 billion GAAP diluted earnings per share from continuing operations of $1.17 Adjusted EPS (2) of $1.84Year-to-date Highlights:
Generated cash flow from operations of $10.2 billion2019 Full Year Guidance:
Revised GAAP operating income guidance range to $11.77 billion to $11.95 billion from $11.82 billion to $12.02 billion Raised and narrowed adjusted operating... More